Skip to Main Content
Table 2

Clinical features and comorbidity at diagnosis of type 2 diabetes

Clinical featureProportion
Asymptomatic 78/225 (35) 
    Acanthosis nigricans 161/221 (73) 
    Obesity* 206/216 (95) 
    Ketosis 46/104 (44) 
    Diabetic ketoacidosis 22/220 (10) 
Comorbidity  
    Polycystic ovarian syndrome 16/132 (12.1) 
    Dyslipidemia 78/174 (44.8) 
    Hypertension 58/205 (28.3) 
    Alanine transferase >90 IU/l or “fatty liver” on ultrasound 39/176 (22.2) 
    Micro-/macroalbuminuria 21/148 (14.2) 
Clinical featureProportion
Asymptomatic 78/225 (35) 
    Acanthosis nigricans 161/221 (73) 
    Obesity* 206/216 (95) 
    Ketosis 46/104 (44) 
    Diabetic ketoacidosis 22/220 (10) 
Comorbidity  
    Polycystic ovarian syndrome 16/132 (12.1) 
    Dyslipidemia 78/174 (44.8) 
    Hypertension 58/205 (28.3) 
    Alanine transferase >90 IU/l or “fatty liver” on ultrasound 39/176 (22.2) 
    Micro-/macroalbuminuria 21/148 (14.2) 

Data are n (%). n = 227.

*BMI >95th percentile for age and sex.

†pH <7.35.

Close Modal

or Create an Account

Close Modal
Close Modal